Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
Clinical trial NCT02609659 · COMPLETED
Trial details
- NCT number
- NCT02609659
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2016-10-07
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.